Avoidant/restrictive food intake disorder prevalence is high in children with gastroparesis and functional dyspepsia.

Autor: Kaul I; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; USDA/ARS Children's Nutrition Research Center, Houston, Texas, USA.; Texas Children's Hospital, Houston, Texas, USA., Burton-Murray H; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., Musaad S; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; USDA/ARS Children's Nutrition Research Center, Houston, Texas, USA., Mirabile Y; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; USDA/ARS Children's Nutrition Research Center, Houston, Texas, USA., Czyzewski D; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Hospital, Houston, Texas, USA., van Tilburg MAL; Cape Fear Valley Health, Fayetteville, North Carolina, USA.; University of North Carolina, Chapel Hill, North Carolina, USA.; University of Washington, Seattle, Washington, USA.; Marshall University, Huntington, West Virginia, USA.; Campbell University, Lillington, North Carolina, USA., Sher AC; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Hospital, Houston, Texas, USA., Chumpitazi BP; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Shulman RJ; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; USDA/ARS Children's Nutrition Research Center, Houston, Texas, USA.; Texas Children's Hospital, Houston, Texas, USA.
Jazyk: angličtina
Zdroj: Neurogastroenterology and motility [Neurogastroenterol Motil] 2024 May; Vol. 36 (5), pp. e14777. Date of Electronic Publication: 2024 Mar 07.
DOI: 10.1111/nmo.14777
Abstrakt: Background: Avoidant/restrictive food intake disorder (ARFID) prevalence in children with gastroparesis (Gp) and/or functional dyspepsia (FD) is unknown. We aimed to identify ARFID prevalence and trajectory over 2 months in children with Gp, FD, and healthy children (HC) using two screening questionnaires. We also explored the frequency of a positive ARFID screen between those with/without delayed gastric emptying or abnormal fundic accommodation.
Methods: In this prospective longitudinal study conducted at an urban tertiary care hospital, patients ages 10-17 years with Gp or FD and age- and gender-matched HC completed two validated ARFID screening tools at baseline and 2-month follow-up: the Nine Item ARFID Screen (NIAS) and the Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire (PARDI-AR-Q). Gastric retention and fundic accommodation (for Gp and FD) were determined from gastric emptying scintigraphy.
Key Results: At baseline, the proportion of children screening positive for ARFID on the NIAS versus PARDI-AR-Q was Gp: 48.5% versus 63.6%, FD: 66.7% versus 65.2%, HC: 15.3% versus 9.7%, respectively; p < 0.0001 across groups. Of children who screened positive at baseline and participated in the follow-up, 71.9% and 53.3% were positive 2 months later (NIAS versus PARDI-AR-Q, respectively). A positive ARFID screen in Gp or FD was not related to the presence/absence of delayed gastric retention or abnormal fundic accommodation.
Conclusions & Inferences: ARFID detected from screening questionnaires is highly prevalent among children with Gp and FD and persists for at least 2 months in a substantial proportion of children. Children with these disorders should be screened for ARFID.
(© 2024 John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: